- Home
- PSNL vs PFLT Comparison
PSNL vs PFLT Comparison
Compare PSNL & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- PFLT
- Stock Information
- Founded
- PSNL 2011
- PFLT 2010
- Country
- PSNL United States
- PFLT United States
- Employees
- PSNL N/A
- PFLT N/A
- Industry
- PSNL Medical Specialities
- PFLT Finance: Consumer Services
- Sector
- PSNL Health Care
- PFLT Finance
- Exchange
- PSNL Nasdaq
- PFLT Nasdaq
- Market Cap
- PSNL 854.8M
- PFLT 906.9M
- IPO Year
- PSNL 2019
- PFLT N/A
- Fundamental
- Price
- PSNL $7.79
- PFLT $9.00
- Analyst Decision
- PSNL Strong Buy
- PFLT Buy
- Analyst Count
- PSNL 7
- PFLT 6
- Target Price
- PSNL $10.43
- PFLT $10.75
- AVG Volume (30 Days)
- PSNL 1.5M
- PFLT 951.6K
- Earning Date
- PSNL 11-04-2025
- PFLT 11-24-2025
- Dividend Yield
- PSNL N/A
- PFLT 13.68%
- EPS Growth
- PSNL N/A
- PFLT N/A
- EPS
- PSNL N/A
- PFLT 0.81
- Revenue
- PSNL $69,103,000.00
- PFLT $247,973,000.00
- Revenue This Year
- PSNL N/A
- PFLT $42.15
- Revenue Next Year
- PSNL $29.83
- PFLT $11.75
- P/E Ratio
- PSNL N/A
- PFLT $11.06
- Revenue Growth
- PSNL N/A
- PFLT 48.88
- 52 Week Low
- PSNL $2.83
- PFLT $8.40
- 52 Week High
- PSNL $10.95
- PFLT $11.50
- Technical
- Relative Strength Index (RSI)
- PSNL 46.21
- PFLT 43.95
- Support Level
- PSNL $6.63
- PFLT $9.05
- Resistance Level
- PSNL $9.89
- PFLT $9.45
- Average True Range (ATR)
- PSNL 0.80
- PFLT 0.17
- MACD
- PSNL -0.21
- PFLT -0.01
- Stochastic Oscillator
- PSNL 32.79
- PFLT 25.60
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.